Following the award of a new ulcerative colitis project, GCT regulatory team has performed the documents submission to the Russian Ministry of Health for obtaining the clinical study approval.
Updated: April 14, 2016
Share this:
Permanent link: https://2022.gctrials.com/news/submissions-update/
BD Contact:
Natalia Katsnelson
Senior Director, Business Development
bd@gctrials.com
telephone: +1 609 921 6868
GMT – 05:00 Eastern time
256 Bunn Drive, Suite 6, Princeton, NJ 08540
BD Contact:
Aleksandr Stiblo
Director, Business Development
bd@gctrials.com
telephone: +7 812 703 0008
GMT + 05:00 Moscow time
23/Z Prof. Popova ul, St. Petersburg, 197376 Russia